Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.

Bone. 2020 Jan;130:115113. doi: 10.1016/j.bone.2019.115113

Kendler DL, Marin F, Geusens P, López-Romero P, Lespessailles E, Body JJ,Minisola S.